Clinical outcomes and healthcare costs among people entering a safer opioid supply program in Ontario
Gomes T, Kolla G, McCormack D, Sereda A, Kitchen S, Antoniou T. CMAJ. 2022; 194(36):E1233-42. Epub 2022 Sep 19.
Publications
Anticoagulant use and associated outcomes in older patients receiving home palliative care: a retrospective cohort study
Chin-Yee N, Gomes T, Tanuseputro P, Talarico R, Laupacis A. CMAJ. 2022; 194(35):E1198-208. Epub 2022 Sep 12.
Correlates of opioid use among Ontario long-term care residents and variation by pain frequency and intensity: a cross-sectional analysis
Iacono A, Campitelli MA, Bronskill SE, Hogan DB, Iaboni A, Maclagan LC, Gomes T, Tadrous M, Evans C, Gruneir A, Guan Q, Hadjistavropoulos T, Cotton C, Gill SS, Seitz DP, Ho J, Maxwell CJ. Drugs Aging. 2022; 39(10):811-27. Epub 2022 Aug 17.
Opioid initiation and the hazard of falls or fractures among older adults with varying levels of central nervous system depressant burden
Guan Q, Men S, Juurlink DN, Bronskill SE, Wunsch H, Gomes T. Drugs Aging. 2022; 39(9):729-38. Epub 2022 Aug 10.
Responding to Ontario’s overdose crisis in the context of the COVID-19 pandemic
Gomes T, Kitchen S, Campbell T, Murray R, Leece P, Kolla G; Ontario Opioid Drug Observatory. Healthc Q. 2022; 25(2):7-12. Epub 2022 Jul 1.
Association of obstructive sleep apnea and opioids use on adverse health outcomes: a population study of health administrative data
Kendzerska T, Gomes T, Malhotra A, Gershon AS, Povitz M, McIsaac DI, Aaron SD, Chung F, Bryson GL, Talarico R, Ahmed T, Godbout M, Tanuseputro P. PLoS One. 2022; 17(6):e0269112. Epub 2022 Jun 28.
Categorization of opioid use among pregnant people and association with overdose or death
Camden A, To T, Ray JG, Gomes T, Bai L, Guttmann A. JAMA Netw Open. 2022; 5(5):e2214688. Epub 2022 May 27.
Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario
Rudoler D, Kurdyak P, Gomes T, Huang A, Jones W, Littleford S, Paracha N, Fischer B. Pharmacoepidemiol Drug Saf. 2022; 31(7):769-78. Epub 2022 Apr 26.
Risk of suicide death following electroconvulsive therapy treatment for depression: a propensity score-weighted, retrospective cohort study in Canada
Kaster TS, Blumberger DM, Gomes T, Sutradhar R, Wijeysundera DN, Vigod SN. Lancet Psychiatry. 2022; 9(6):435-46. Epub 2022 Apr 26.
Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: a population-based study
Antoniou T, Men S, Tadrous M, Leece P, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109473. Epub 2022 Apr 26.